Ignite Creation Date:
2024-05-05 @ 4:47 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00311662
Status:
COMPLETED
Last Update Posted:
2009-08-31
First Post:
2006-04-04
Brief Title:
Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
Sponsor:
Minster Research Ltd
Organization:
Minster Research Ltd
Study Overview
Official Title:
Multi-centre Parallel Group Double-blind Placebo Controlled Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
Status:
COMPLETED
Status Verified Date:
2009-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Overall trial objectives
Can treatment with tonabersat reduce the number of days with a migraine headache in patients who suffer from frequent migraine attacks
How well tolerated is treatment with tonabersat
The study is based on the hypothesis that the unique mechanism of action of tonabersat will inhibit some of the early events in the generation of migraine and so be effective as prophylactic treatment
Can treatment with tonabersat reduce the number of days with a migraine headache in patients who suffer from frequent migraine attacks
How well tolerated is treatment with tonabersat
The study is based on the hypothesis that the unique mechanism of action of tonabersat will inhibit some of the early events in the generation of migraine and so be effective as prophylactic treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None